Duff & Phelps Investment Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65M Buy
3,331,616
+503,171
+18% +$9.98M 0.61% 64
2026
Q1
$54.4M Buy
2,828,445
+39,650
+1% +$781K 0.56% 64
2025
Q4
$52.8M Buy
2,788,795
+315,807
+13% +$5.85M 0.6% 61
2025
Q3
$46.1M Sell
2,472,988
-76,450
-3% -$1.43M 0.52% 69
2025
Q2
$47M Buy
2,549,438
+16,069
+0.6% +$285K 0.55% 65
2025
Q1
$44.3M Sell
2,533,369
-6,380
-0.3% -$108K 0.52% 66
2024
Q4
$44M Buy
2,539,749
+356,030
+16% +$6.5M 0.53% 66
2024
Q3
$40.6M Buy
2,183,719
+156,309
+8% +$2.64M 0.47% 72
2024
Q2
$31.2M Sell
2,027,410
-149,045
-7% -$2.13M 0.4% 79
2024
Q1
$32.1M Buy
2,176,455
+74,860
+4% +$1.04M 0.39% 77
2023
Q4
$30M Buy
2,101,595
+778,355
+59% +$11.1M 0.36% 79
2023
Q3
$18.4M Buy
+1,323,240
New +$16.9M 0.24% 97

Other funds holding SBRA

Duff & Phelps Investment Management's SBRA Position: Q2 2026 in Review

Duff & Phelps Investment Management increased its Sabra Healthcare REIT (SBRA) stake by 18% in Q2 2026, buying an estimated $9.98M and bringing the position to 3,331,616 shares worth $65M. The position accounts for 0.61% of the portfolio, ranked #64.

Duff & Phelps Investment Management first reported a position in SBRA in Q3 2023 and has held it in 12 quarters since. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Duff & Phelps Investment Management held 3,331,616 shares of Sabra Healthcare REIT worth $65M as of Q2 2026.
  • Duff & Phelps Investment Management bought 503,171 Sabra Healthcare REIT shares in Q2 2026, an estimated $9.98M.
  • Sabra Healthcare REIT made up 0.61% of Duff & Phelps Investment Management's portfolio in Q2 2026, its #64 holding.
  • Duff & Phelps Investment Management first reported a position in Sabra Healthcare REIT in Q3 2023 and has held it in 12 quarters since.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Duff & Phelps Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.